{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:01:06Z","timestamp":1784764866024,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Basic and Clincal Cooperative Research and Promotion Program of Anhui Medical University","award":["2023xkjT033"],"award-info":[{"award-number":["2023xkjT033"]}]},{"name":"the Key Project of Natural Science Foundation of Anhui Provincial Department of Education","award":["2023 AH053299"],"award-info":[{"award-number":["2023 AH053299"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16159-z","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:15:14Z","timestamp":1779768914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrin-binding sialoprotein as an extracellular matrix\u2013associated independent prognostic biomarker in glioma"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei-wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-xing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-qing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-you","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-dong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"2","key":"16159_CR1","doi-asserted-by":"publisher","first-page":"E924","DOI":"10.3390\/ijms22020924","volume":"22","author":"A Finch","year":"2021","unstructured":"Finch A, Solomou G, Wykes V, et al. Advances in research of adult gliomas. Int J Mol Sci. 2021;22(2):E924.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"16159_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"Supplement3","key":"16159_CR3","first-page":"iii1","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neurooncology. 2021;23(Supplement3):iii1\u2013105.","journal-title":"Neurooncology"},{"issue":"6","key":"16159_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803\u201320.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"16159_CR5","first-page":"1231","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neurooncology. 2021;23(8):1231\u201351.","journal-title":"Neurooncology"},{"issue":"26","key":"16159_CR6","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma Groups Based on 1p\/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015;372(26):2499\u2013508.","journal-title":"N Engl J Med"},{"issue":"1","key":"16159_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang K, Wu Z, Zhang H, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):39.","journal-title":"Mol Cancer"},{"issue":"10","key":"16159_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/carcin\/bgz102","volume":"40","author":"RC Chai","year":"2019","unstructured":"Chai RC, Zhang KN, Chang YZ, et al. Systematically characterize the clinical and biological significances of 1p19q genes in 1p\/19q non-codeletion glioma. Carcinogenesis. 2019;40(10):1229\u201339.","journal-title":"Carcinogenesis"},{"issue":"1","key":"16159_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0022034519885089","volume":"99","author":"A Vijaykumar","year":"2020","unstructured":"Vijaykumar A, Dyrkacz P, Vidovic-Zdrilic I, et al. Expression of BSP-GFPtpz Transgene during Osteogenesis and Reparative Dentinogenesis. J Dent Res. 2020;99(1):89\u201397.","journal-title":"J Dent Res"},{"key":"16159_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.matbio.2015.12.011","volume":"52\u201354","author":"W Bouleftour","year":"2016","unstructured":"Bouleftour W, Juignet L, Bouet G, et al. The role of the SIBLING, Bone Sialoprotein in skeletal biology \u2014 Contribution of mouse experimental genetics. Matrix Biol. 2016;52\u201354:60\u201377.","journal-title":"Matrix Biol"},{"issue":"1","key":"16159_CR11","doi-asserted-by":"publisher","first-page":"9750","DOI":"10.1038\/s41598-018-28201-7","volume":"8","author":"M Luedde","year":"2018","unstructured":"Luedde M, Roy S, Hippe HJ, et al. Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients. Sci Rep. 2018;8(1):9750.","journal-title":"Sci Rep"},{"issue":"4","key":"16159_CR12","doi-asserted-by":"publisher","first-page":"e0231701","DOI":"10.1371\/journal.pone.0231701","volume":"15","author":"F Benz","year":"2020","unstructured":"Benz F, Bogen A, Praktiknjo M, et al. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis. PLoS ONE. 2020;15(4):e0231701.","journal-title":"PLoS ONE"},{"issue":"1","key":"16159_CR13","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-021-25473-y","volume":"12","author":"K Wu","year":"2021","unstructured":"Wu K, Feng J, Lyu F, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12(1):5196.","journal-title":"Nat Commun"},{"issue":"2","key":"16159_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/genes12020182","volume":"12","author":"A Misawa","year":"2021","unstructured":"Misawa A, Kondo Y, Takei H, et al. Long Noncoding RNA HOXA11-AS and Transcription Factor HOXB13 Modulate the Expression of Bone Metastasis-Related Genes in Prostate Cancer. Genes. 2021;12(2):182.","journal-title":"Genes"},{"issue":"12","key":"16159_CR15","first-page":"4060","volume":"7","author":"NS Fedarko","year":"2001","unstructured":"Fedarko NS, Jain A, Karadag A, et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2001;7(12):4060\u20136.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"16159_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.omtn.2021.02.008","volume":"23","author":"L Hu","year":"2021","unstructured":"Hu L, Liu J, Xue H, et al. miRNA-92a-3p regulates osteoblast differentiation in patients with concomitant limb fractures and TBI via IBSP\/PI3K-AKT inhibition. Molecular Therapy. Nucleic Acids. 2021;23:1345\u201359.","journal-title":"Nucleic Acids"},{"issue":"8","key":"16159_CR17","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.3390\/ijms23084157","volume":"23","author":"CH Lu","year":"2022","unstructured":"Lu CH, Wei ST, Liu JJ, et al. Recognition of a Novel Gene Signature for Human Glioblastoma. Int J Mol Sci. 2022;23(8):4157.","journal-title":"Int J Mol Sci"},{"key":"16159_CR18","unstructured":"Phase I. II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response - PubMed[EB\/OL]. 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/25962426\/."},{"issue":"2","key":"16159_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"16159_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13046-019-1341-6","volume":"38","author":"E Bian","year":"2019","unstructured":"Bian E, Chen X, Xu Y, et al. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma. J experimental Clin cancer research: CR. 2019;38(1):366.","journal-title":"J experimental Clin cancer research: CR"},{"key":"16159_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3389\/fonc.2019.01117","volume":"9","author":"M Wang","year":"2019","unstructured":"Wang M, Liu B, Li D, et al. Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma. Front Oncol. 2019;9:1117.","journal-title":"Front Oncol"},{"issue":"10145","key":"16159_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet (London England). 2018;392(10145):432\u201346.","journal-title":"Lancet (London England)"},{"issue":"6","key":"16159_CR23","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1158\/0008-5472.CAN-10-3213","volume":"71","author":"EM Goellner","year":"2011","unstructured":"Goellner EM, Grimme B, Brown AR, et al. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 2011;71(6):2308\u201317.","journal-title":"Cancer Res"},{"issue":"7","key":"16159_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","volume":"10","author":"W Wick","year":"2014","unstructured":"Wick W, Weller M, van den Bent M, et al. MGMT testing\u2013the challenges for biomarker-based glioma treatment. Nat Reviews Neurol. 2014;10(7):372\u201385.","journal-title":"Nat Reviews Neurol"},{"issue":"11","key":"16159_CR25","first-page":"1580","volume":"22","author":"R Mathur","year":"2020","unstructured":"Mathur R, Zhang Y, Grimmer MR, et al. MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Neurooncology. 2020;22(11):1580\u201390.","journal-title":"Neurooncology"},{"issue":"3","key":"16159_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11060-017-2477-x","volume":"133","author":"RJ Diaz","year":"2017","unstructured":"Diaz RJ, Ali S, Qadir MG, et al. The role of bevacizumab in the treatment of glioblastoma. J Neurooncol. 2017;133(3):455\u201367.","journal-title":"J Neurooncol"},{"issue":"9","key":"16159_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s11547-021-01381-5","volume":"126","author":"B Detti","year":"2021","unstructured":"Detti B, Scoccianti S, Teriaca MA, et al. Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients. Radiol Med. 2021;126(9):1249\u201354.","journal-title":"Radiol Med"},{"issue":"5","key":"16159_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"16159_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4161\/auto.8792","volume":"5","author":"MA Tyler","year":"2009","unstructured":"Tyler MA, Ulasov IV, Lesniak MS. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy. Autophagy. 2009;5(6):856\u20137.","journal-title":"Autophagy"},{"key":"16159_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4103\/wjtcm.wjtcm_6_21","volume":"8","author":"F Rabbani","year":"2022","unstructured":"Rabbani F, Yazdiniapour Z, Ghanadian M, Zolfaghari B, Maleki M, Shafiee F. Cytotoxicity and apoptosis assay of novel cyclomyrsinol diterpenes against breast cancer cell lines. World J Tradit Chin Med. 2022;8:273\u20137.","journal-title":"World J Tradit Chin Med"},{"issue":"2","key":"16159_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-021-03865-w","volume":"155","author":"S Yerrabothala","year":"2021","unstructured":"Yerrabothala S, Gourley BL, Ford JC, et al. Systemic coagulation is activated in patients with meningioma and glioblastoma. J Neurooncol. 2021;155(2):173\u201380.","journal-title":"J Neurooncol"},{"issue":"11\u201312","key":"16159_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00335-018-9761-8","volume":"29","author":"A Cho","year":"2018","unstructured":"Cho A, McKelvey KJ, Lee A, et al. The intertwined fates of inflammation and coagulation in glioma. Mammalian Genome: Official J Int Mammalian Genome Soc. 2018;29(11\u201312):806\u201316.","journal-title":"Mammalian Genome: Official J Int Mammalian Genome Soc"},{"key":"16159_CR33","doi-asserted-by":"publisher","first-page":"615970","DOI":"10.3389\/fcell.2020.615970","volume":"8","author":"X Cai","year":"2020","unstructured":"Cai X, Qiu W, Qian M, et al. A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma. Front Cell Dev Biology. 2020;8:615970.","journal-title":"Front Cell Dev Biology"},{"key":"16159_CR34","doi-asserted-by":"publisher","first-page":"600248","DOI":"10.3389\/fgene.2020.600248","volume":"11","author":"L Meng","year":"2020","unstructured":"Meng L, Tian Z, Long X, et al. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining. Front Genet. 2020;11:600248.","journal-title":"Front Genet"},{"issue":"1","key":"16159_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jcmm.17061","volume":"26","author":"B Chao","year":"2022","unstructured":"Chao B, Jiang F, Bai H, et al. Predicting the prognosis of glioma by pyroptosis-related signature. J Cell Mol Med. 2022;26(1):133\u201343.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"16159_CR36","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1021\/bi0616697","volume":"46","author":"S Lima","year":"2007","unstructured":"Lima S, Khristoforov R, Momany C, et al. Crystal structure of Homo sapiens kynureninase. Biochemistry. 2007;46(10):2735\u201344.","journal-title":"Biochemistry"},{"issue":"2","key":"16159_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/ced.14072","volume":"45","author":"C Ci","year":"2020","unstructured":"Ci C, Wu C, Lyu D, et al. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K\/AKT pathway. Clin Exp Dermatol. 2020;45(2):194\u2013201.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"16159_CR38","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/annonc\/mdy082","volume":"29","author":"AM Rose","year":"2018","unstructured":"Rose AM, Krishan A, Chakarova CF, et al. MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2018;29(5):1292\u2013303.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"9","key":"16159_CR39","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/cam4.4603","volume":"11","author":"Q Ji","year":"2022","unstructured":"Ji Q, Huang K, Jiang Y, et al. Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower-grade gliomas. Cancer Med. 2022;11(9):2020\u201335.","journal-title":"Cancer Med"},{"issue":"8","key":"16159_CR40","doi-asserted-by":"publisher","first-page":"e1460","DOI":"10.1002\/onco.13750","volume":"26","author":"F Zeng","year":"2021","unstructured":"Zeng F, Li G, Liu X, et al. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma. Oncologist. 2021;26(8):e1460\u20139.","journal-title":"Oncologist"},{"issue":"11","key":"16159_CR41","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1007\/s00432-021-03762-9","volume":"147","author":"R Mao","year":"2021","unstructured":"Mao R, Zhou L, Yang Y, et al. Regulation of prognosis-related Siglecs in the glioma microenvironment. J Cancer Res Clin Oncol. 2021;147(11):3343\u201357.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Pt 2","key":"16159_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/bj3290321","volume":"329","author":"NT Price","year":"1998","unstructured":"Price NT, Jackson VN, Halestrap AP. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J. 1998;329(Pt 2):321\u20138.","journal-title":"Biochem J"},{"key":"16159_CR43","doi-asserted-by":"publisher","first-page":"6655529","DOI":"10.1155\/2021\/6655529","volume":"2021","author":"AM Reuss","year":"2021","unstructured":"Reuss AM, Groos D, Ghoochani A, et al. MCT4 Promotes tumor malignancy in F98 glioma cells. J Oncol. 2021;2021:6655529.","journal-title":"J Oncol"},{"issue":"1","key":"16159_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/1078-0432.CCR-20-2649","volume":"27","author":"JF Zeidner","year":"2021","unstructured":"Zeidner JF, Lee DJ, Frattini M, et al. Phase I Study of Alvocidib Followed by 7\u2009+\u20093 (Cytarabine\u2009+\u2009Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia. Clin Cancer Research: Official J Am Association Cancer Res. 2021;27(1):60\u20139.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"16159_CR45","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1038\/s41598-021-84082-3","volume":"11","author":"M Buzzetti","year":"2021","unstructured":"Buzzetti M, Morlando S, Solomos D, et al. Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells. Sci Rep. 2021;11(1):5374.","journal-title":"Sci Rep"},{"issue":"3","key":"16159_CR46","first-page":"341","volume":"10","author":"DA Haas-Kogan","year":"2008","unstructured":"Haas-Kogan DA, Banerjee A, Kocak M, et al. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neurooncology. 2008;10(3):341\u20137.","journal-title":"Neurooncology"},{"issue":"8","key":"16159_CR47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/jir.2012.0002","volume":"32","author":"Z Du","year":"2012","unstructured":"Du Z, Whitt MA, Baumann J, et al. Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1. J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res. 2012;32(8):368\u201377.","journal-title":"J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res"},{"issue":"6","key":"16159_CR48","doi-asserted-by":"publisher","first-page":"e0251272","DOI":"10.1371\/journal.pone.0251272","volume":"16","author":"Y Takashima","year":"2021","unstructured":"Takashima Y, Kawaguchi A, Fukai J, et al. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PLoS ONE. 2021;16(6):e0251272.","journal-title":"PLoS ONE"},{"issue":"11","key":"16159_CR49","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/cells8111312","volume":"8","author":"Y Takashima","year":"2019","unstructured":"Takashima Y, Kawaguchi A, Yamanaka R. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma. Cells. 2019;8(11):1312.","journal-title":"Cells"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16159-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:03:46Z","timestamp":1784761426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16159"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16159-z","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of the First Affiliated Hospital of Anhui Medical University (Quick \u2013 PJ 2022-12-27). All clinical samples involved in this study have been informed consent of the patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"882"}}